FDA Inspection 987176 — Invitrx Therapeutics, Inc

Invitrx Therapeutics, Inc — FEI 3004168148

The FDA completed an inspection of Invitrx Therapeutics, Inc on September 26, 2016 in Irvine, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 26, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Irvine, CA (United States)